A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II/III Study to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors
Latest Information Update: 16 Feb 2026
At a glance
- Drugs SHR-1918 (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors Beijing Suncadia Pharmaceuticals
Most Recent Events
- 16 Feb 2026 New trial record